TY - JOUR
AU - Hall, Andrew J.
AU - Clement, Nicholas D.
AU - Farrow, Luke
AU - MacLullich, Alasdair M.J.
AU - Dall, Graham F.
AU - Scott, Chloe E. H.
AU - Jenkins, Paul J.
AU - White, Timothy O
AU - Duckworth, Andrew D.
AU - IMPACT-Scot Study Group
PY - 2020
DA - September
TI - IMPACT-Scot report on COVID-19 and hip fractures: a multicentre study assessing mortality, predictors of early SARS-CoV-2 infection, and the effects of social lockdown on epidemiology
JO - Bone and Joint Journal
EP - 10
VL - 102-B
IS - 10
DO - https://doi.org/10.1302/0301-620X.102B9.BJJ-2020-1100.R1
AB - Aims: The primary aim was to assess the independent influence of coronavirus disease (COVID-19) on 30-day mortality for patients with a hip fracture. The secondary aims were to determine whether: 1) there were clinical predictors of COVID-19 status; and 2) whether social lockdown influenced the incidence and epidemiology of hip fractures.Methods: A national multicentre retrospective study was conducted of all patients presenting to six trauma centres or units with a hip fracture over a 46-day period (23 days pre- and 23 days post-lockdown). Patient demographics, type of residence, place of injury, presentation blood tests, Nottingham Hip Fracture Score, time to surgery, operation, American Society of Anesthesiologists (ASA) grade, anaesthetic, length of stay, COVID-19 status, and 30-day mortality were recorded.Results: Of 317 patients with acute hip fracture, 27 (8.5%) had a positive COVID-19 test. Only seven (26%) had suggestive symptoms on admission. COVID-19-positive patients had a significantly lower 30-day survival compared to those without COVID-19 (64.5%, 95% confidence interval (CI) 45.7 to 83.3 vs 91.7%, 95% CI 88.2 to 94.8; p &lt; 0.001). COVID-19 was independently associated with increased 30-day mortality risk adjusting for: 1) age, sex, type of residence (hazard ratio (HR) 2.93; p = 0.008); 2) Nottingham Hip Fracture Score (HR 3.52; p = 0.001); and 3) ASA (HR 3.45; p = 0.004). Presentation platelet count predicted subsequent COVID-19 status; a value of &lt; 217 × 109/l was associated with 68% area under the curve (95% CI 58 to 77; p = 0.002) and a sensitivity and specificity of 63%. A similar number of patients presented with hip fracture in the 23 days pre-lockdown (n = 160) and 23 days post-lockdown (n = 157) with no significant (all p ≥ 0.130) difference in patient demographics, residence, place of injury, Nottingham Hip Fracture Score, time to surgery, ASA, or management.Conclusion: COVID-19 was independently associated with an increased 30-day mortality rate for patients with a hip fracture. Notably, most patients with hip fracture and COVID-19 lacked suggestive symptoms at presentation. Platelet count was an indicator of risk of COVID-19 infection. These findings have implications for the management of hip fractures, in particular the need for COVID-19 testing.Keywords: COVID-19; Coronavirus; Femoral neck fracture; Hip fracture; Mortality; Neck of femur fracture; Outcomes; Platelets; Predictors; SARS-CoV-2.
PB - Bone & Joint Publishing
UR - https://www.research.ed.ac.uk/portal/en/publications/impactscot-report-on-covid19-and-hip-fractures(2d0db5a5-393e-4969-a6b8-c1ab4f976b47).html
KW - Coronavirus (COVID-19)
KW - Hospital care
ER